Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 090873

Expand all

CLONIDINE (CLONIDINE)
0.1MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CLONIDINE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.1MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090873
Product Number: 001
Approval Date: May 6, 2014
Applicant Holder Full Name: ACTAVIS LABORATORIES UT INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLONIDINE (CLONIDINE)
0.2MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CLONIDINE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.2MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090873
Product Number: 002
Approval Date: May 6, 2014
Applicant Holder Full Name: ACTAVIS LABORATORIES UT INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLONIDINE (CLONIDINE)
0.3MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CLONIDINE
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.3MG/24HR
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090873
Product Number: 003
Approval Date: May 6, 2014
Applicant Holder Full Name: ACTAVIS LABORATORIES UT INC
Marketing Status:  Prescription
Patent and Exclusivity Information